Presumed Ocular Histoplasmosis (POHS)

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Presumed Ocular Histoplasmosis (POHS) trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

UnknownPhase 2

NCT00546936

Ranibizumab Versus PDT for Presumed Ocular Histoplasmosis

The purpose of this study is to evaluate the change in visual activity of ranibizumab to Photodynamic Therapy (PDT)in patients with choroidal neovascularization…

United States30 participantsStarted 2007-10

Treatment: ranibizumab, verteporfin